Clonal Evolution of Pre-Leukemic Hematopoietic Stem Cells in Human Myeloid Malignancies


IN PARTNERSHIP WITH LEUKEMIA & LYMPHOMA SOCIETY AND THE PAUL G. ALLEN FRONTIERS GROUP (2020-PRESENT)

Ravi Majeti, MD, PhD, Stanford University School of Medicine

Dr. Majeti is generating cell-based models to test the progression of preleukemic cells into acute myeloid leukemia (AML). His lab will use these models to test potential therapies and the role of the microenvironment in disease progression.

BACK TO OUR PORTFOLIO